JI
Iglesias, Juan Fernando
Affiliation entities
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Two-year clinical outcomes of resorbable magnesium scaffold versus conventional drug-eluting stents in ST-segment elevation myocardial infarction : A propensity score matching analysis | Hellenic Journal of Cardiology | 2024 | 16 | 4 | |||
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions : 6-month results of the prospective, multicenter BIOMAG-I first-in-human study | EClinicalMedicine | 2023 | 18 | 2 | |||
Vascular access in percutaneous coronary intervention of chronic total occlusions : a state-of-the-art review | Circulation. Cardiovascular interventions | 2023 | 16 | 0 | |||
Défis de la revascularisation coronarienne du patient diabétique en 2023 | Revue médicale suisse | 2023 | 20 | 1 | |||
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions : A lesion-level subgroup analysis of 2 randomized trials | American heart journal | 2023 | 17 | 3 | |||
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction : 5-year follow-up of the BIOSTEMI randomised superiority trial | Lancet | 2023 | 21 | 0 | |||
Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring : the global paradise system registry study design | Clinical research in cardiology | 2023 | 16 | 4 | |||
Five-year outcomes with Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in patients with Acute Coronary Syndrome: A subgroup analysis of the BIOSCIENCE Trial | Cardiovascular revascularization medicine | 2022 | 135 | 52 | |||
Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation | Cardiology Journal | 2022 | 118 | 69 | |||
Extremity Dysfunction After Large-Bore Radial and Femoral Arterial Access | Journal of the American Heart Association | 2022 | 299 | 78 | |||
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study | The American heart journal | 2022 | 120 | 55 | |||
The persistent illusion of using coronary angiography alone to guide decision-making for myocardial revascularization | European journal of cardio-thoracic surgery | 2021 | 124 | 28 | |||
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials | American heart journal | 2021 | 170 | 120 | |||
Prevention of radial artery occlusion: don't forget the basics | JACC. Cardiovascular interventions | 2021 | 85 | 45 | |||
Randomized comparison between radial and femoral large-bore access for complex percutaneous coronary intervention | JACC. Cardiovascular interventions | 2021 | 159 | 0 | |||
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial | The American heart journal | 2021 | 160 | 0 | |||
Successful percutaneous mechanical thrombectomy of an Impella CP-related femoral artery thrombosis | Cardiology Journal | 2021 | 159 | 25 | |||
Biodegradable-Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial | JACC. Cardiovascular interventions | 2021 | 273 | 36 | |||
The dynamic effect of coronary artery bypass grafting on the instantaneous wave-free ratio in the collateral donor artery of a patient with chronic total occlusion | European journal of cardio-thoracic surgery | 2021 | 99 | 0 | |||
Differential effects of newer-generation ultrathin-strut versus thicker-strut drug-eluting stents in chronic and acute coronary syndromes | JACC. Cardiovascular interventions | 2021 | 166 | 67 | |||
Combined cardiac PET-CT and transcatheter closure for left internal mammary artery side branch steal syndrome | JACC. Case reports. | 2021 | 102 | 80 | |||
Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage | Cardiology Journal | 2021 | 136 | 41 | |||
Coronary steal syndrome: A greedy neighbour! | Cardiology Journal | 2021 | 120 | 46 | |||
Sol ana koroner hastalığında perkütan koroner girişim: Tutarsızlıkları uzlaştırma arayışı | Türk kardiyoloji derneği arşivi | 2021 | 115 | 23 | |||
Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial | International journal of cardiology | 2021 | 137 | 24 | |||
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification | European heart journal. Cardiovascular imaging | 2020 | 94 | 0 | |||
Refining outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention | 2020 | 355 | 1 | ||||
Covered stents for the percutaneous management of delayed coronary wall rupture following subadventitial rotational atherectomy | JACC. Case reports. | 2020 | 70 | 63 | |||
Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial | JACC. Cardiovascular interventions | 2020 | 82 | 37 | |||
Intravascular lithotripsy to treat an ostial left main coronary artery stenosis due to porcelain aorta in a patient with congenital high-density lipoprotein deficiency | Anatolian Journal of Cardiology | 2020 | 174 | 70 | |||
Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy | The international journal of cardiovascular imaging | 2020 | 102 | 110 | |||
Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study | American journal of cardiovascular drugs | 2020 | 115 | 69 | |||
Multisite vascular disease in acute coronary syndromes: increased in-hospital mortality and no improvement over time | European heart journal. Acute cardiovascular care | 2020 | 92 | 0 | |||
Impact of the COVID-19 pandemic on acute coronary syndromes | Swiss Medical Weekly | 2020 | 259 | 116 | |||
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial | The Lancet | 2019 | 148 | 255 | |||
The 'de Winter' electrocardiogram pattern as a ST-elevation myocardial infarction equivalent: a case report | European Heart Journal: Case reports | 2019 | 213 | 159 |